During a plenary session at the American College of Chest Physicians' CHEST meeting in Austin, Texas, Edgar Jimenez, MD, FCCM, vice president of critical care integration at Baylor Scott and White Health in Central Texas, discussed how to prepare for Ebola in the Intensive Care Unit (ICU) setting. Dr Jimenez began by introducing the session as a way to answer questions and to provide hospital ICU staff with key considerations for Ebola preparation in the United States.
During a plenary session at the American College of Chest Physicians’ CHEST meeting in Austin, Texas, Edgar Jimenez, MD, FCCM, vice president of critical care integration at Baylor Scott and White Health in Central Texas, discussed how to prepare for Ebola in the Intensive Care Unit (ICU) setting. Dr Jimenez began by introducing the session as a way to answer questions and to provide hospital ICU staff with key considerations for Ebola preparation in the United States.
Key considerations for Ebola preparedness include: setting up a clinical chain of command, making provisions for personal protective equipment, and planning for waste management, clinical care, and transport.
While infection control measures have been in place in the critical care community for many years, according to Dr Jimenez, these measures have not been strictly applied. The sudden acute respiratory syndrome (SARS) epidemic of 2003 revealed several problems with infection control procedures. Recommendations were poorly followed, and violations of protocol were common, he noted. Using 1 SARS isolation unit as an example, he described protocol violations ranging from the use of open bays for patient isolation, to using the incorrect type of mask, to inconsistent use of eye protection or gowns.
Use of powered air purifying respirators (PAPRs), N95 masks, double gowning, and double gloving is necessary to reduce the risk of spreading SARS, but even those measures have been insufficient, Dr Jimenez said. Experience with SARS in Canada shows that, even when proper regulations are followed, transmission occurs.1
One of the problems identified in a paper by Zamora et al published in 2006 is the threat of aerosolization in compromising PAPR gear. This paper showed that, even when CDC recommendations are followed, there is a 4% chance of contaminating the face, and a 96% chance of contaminating the neck with aerosols from the patient. This risk can be reduced by adding a hood layer over the PAPR, which reduces the risk of spread to the facial area to 2%, and reduces the risk of spread to the neck to 18%. However, the risks of spread are virtually unavoidable unless strict protocols are followed.2
The neck and wrists were identified as areas vulnerable to contamination—even with the use of recommended protective gear (see image here).2 As a result of this research, it is clear that, even with highly protective systems, checklists are needed, and adherence to proper donning technique is critical. In the current Ebola outbreak, one of the most important recommendations for reducing the risk of spread in healthcare is avoidance of absorbable materials in shoes. Shoes should be made of rubber or another material impermeable to infectious liquids. Another recommendation involves longitudinal taping of gloves. By taping gloves to full-body suits longitudinally along the wrists, it is possible to remove the gown or system in a single motion. This reduces the risk of compromising the wrists, which are often contaminated by removal of gloves. In addition, cleaning between steps and constant spraying with bleach are necessary for full infection control.
Dr Jimenez works with 43 Texas hospitals that serve a total area the size of Massachusetts, Vermont, and New Hampshire combined. For a system this large, he noted, the importance of a centralized command system to organize resources in an emergency is very important.
In this session, Dr Jimenez was joined by experts Michael Connor Jr, MD, of Emory University, and Lewis Rubinson, MD, PhD, of Baltimore Shock Trauma at the University of Maryland Medical Center. Dr Rubinson had recently returned from West Africa and has firsthand experience fighting Ebola in Liberia.
Providing a rare insight into day-to-day Ebola care, Dr Rubinson stated, “You will not be impressed by how ill these patients are....You see much sicker patients every day.” Organ dysfunction, shock, and secondary infections in Ebola are, in Dr Rubinson’s words, “[nowhere] near the extreme of someone with H1N1.” Important care principles include creative use of bedside ultrasound, use of optic nerve inspection to measure intracranial pressures, and finding ways to make diagnostic decisions when radiology and other tests cannot be performed on patients. Establishing central line access in all patients with incident cases of Ebola is also critical to reduce the risk of needle sticks.
Scientists have known for years that even full protective gear is not 100% effective. Care centers around the country and around the world can do more to contain the spread of not only Ebola, but of other viral illnesses, through proper use of protective equipment, noted Dr Jimenez.
Several organizations around the world offer resources to help prepare for these critical tasks, including:
REFERENCES
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More